Alzheon To Present At The 22nd Annual NewsMakers In The Biotech Industry Conference

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders, today announced that Martin Tolar, M.D., Ph.D., Founder, President and Chief Executive Officer, will present at the 22nd Annual NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel on Thursday, September 10, 2015 at 10:30 a.m. Eastern Time in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

Back to news